![William Grossman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
William Grossman is the founder of Children's Hospital of Wisconsin, Inc. Current positions include Director & Chief Medical Officer at enGene Therapeutics, Inc. starting in 2026, Director at Tizona Therapeutics, Inc., and Director at Pionyr Immunotherapeutics, Inc. Former positions include Group Director-Medical at Genentech, Inc. from 2015 to 2018, Director at Bryologyx, Inc., Independent Director at Day One Biopharmaceuticals, Inc. from 2024 to 2026, Senior Vice President, Head-Research & Development at Biothera, Inc. from 2011 to 2013, Chief Medical Officer at Bellicum Pharmaceuticals, Inc. from 2018 to 2019, Professor at The Medical College of Wisconsin, Inc., Senior VP-Oncology Clinical Development at Gilead Sciences, Inc. from 2021 to 2024, and Chief Medical Officer at Arcus Biosciences, Inc. from 2019 to 2021.
Education includes undergraduate studies at the University of St. Thomas and a doctorate from Washington University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 15/06/2026 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Direttore/Membro del Consiglio | - |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 23/04/2026 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/08/2024 |
Bryologyx, Inc.
 Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Direttore/Membro del Consiglio | 21/12/2021 |
| ARCUS BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 16/07/2021 |
| BELLICUM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of St. Thomas
 University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Medical College of Wisconsin, Inc.
 The Medical College of Wisconsin, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Children's Hospital of Wisconsin, Inc.
 Children's Hospital of Wisconsin, Inc. Hospital/Nursing ManagementHealth Services Operates as children's hospital | Health Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
